Daniel Mahony
Presidente en TRELLUS HEALTH PLC .
Fortuna: 5 353 $ al 30/04/2024
Origen de la red de primer grado Daniel Mahony.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Polar Capital LLP
Polar Capital LLP Investment ManagersFinance Polar Capital LLP is an alternative investment manager headquartered in London, UK. The firm is a subsidiary of Polar Capital Partners Ltd., itself a subsidiary of Polar Capital Holdings, Plc (LON: POLR) in Great Britain. Founded in 2001, Polar Capital offers its services primarily to Polar Funds and managed accounts, all of which are pooled investment vehicles. Investors in Polar Funds include individuals, banking or thrift institutions, investment companies (including mutual funds), pension and profit-sharing plans, pooled investment vehicles (such as hedge funds), high net-worth individuals, collateralized debt obligations (CDO’s), charitable organizations, trusts and estates, corporations and other business entities, and state or municipal government entities.
90
| Subsidiary | Investment Managers | 90 |
The Bioindustry Association
The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012.
21
| Non-Profit Organization | Miscellaneous Commercial Services | 21 |
Public Company | Biotechnology | 15 | |
Novo Holdings AS (Denmark)
Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark.
14
| Subsidiary | Financial Conglomerates | 14 |
Genome Research Ltd.
Genome Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of The Wellcome Trust Ltd., Genome Research Ltd. is a world-leading genomics research institute founded in 1992. The company is based in Cambridge, UK. Genome Research delivers therapeutic, diagnostic, and production benefits in areas such as cancer, immunology, public health, and personalized treatment. The British company tackle some of the most difficult challenges in genomic research, demanding science at scale and a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. The company's work helps improve human health and understand life on a molecular level.
11
| Subsidiary | Miscellaneous Commercial Services | 11 |
Public Company | Internet Software/Services | 11 | |
Celmatix, Inc.
Celmatix, Inc. Pharmaceuticals: MajorHealth Technology Celmatix, Inc. operates as a personalized medicine company that focuses on women?s health. It offers POLARIS, a web-based analytics platform for optimizing a woman?s fertility; and NOVA, a patient portal that helps clinics to maximize the patient experience. Its products help women to make informed decisions about their fertility, as well as provide doctors with data-driven tools for patient care. The company was founded by Piraye Yurttas Beim and Laura Towart Bandak in 2009 and is headquartered New York, NY.
9
| Holding Company | Pharmaceuticals: Major | 9 |
Wellcome Trust Sanger Institute
Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom.
5
| Subsidiary | Biotechnology | 5 |
Keepabl Ltd.
Keepabl Ltd. Packaged SoftwareTechnology Services Keepabl Ltd. provides Privacy Management Software to automate and streamline GDPR compliance. The company is based in London, UK. The British company's software solution and Privacy Policy Pack help set up a Privacy Framework quickly and easily. The company was founded in 2017 by Robert Baugh, who has been the CEO since 2017.
1
| Holding Company | Packaged Software | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Daniel Mahony a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
INCYTE CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
The Wellcome Trust Ltd.
The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Chief Executive Officer | |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Investment Managers | Private Equity Investor Private Equity Analyst | |
NOVO NORDISK A/S | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Director/Board Member | |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Medical Specialties | Chief Tech/Sci/R&D Officer Director/Board Member | |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
TEARLAB CORPORATION | Medical Specialties | Corporate Officer/Principal | |
The Medical Research Council
The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Chief Tech/Sci/R&D Officer | |
GALAPAGOS NV | Biotechnology | Director/Board Member | |
NOVARTIS AG | Pharmaceuticals: Major | Investor Relations Contact Director of Finance/CFO | |
University of Pennsylvania | College/University | Undergraduate Degree Doctorate Degree | |
Novo Nordisk Fonden
Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Chairman Chief Executive Officer | |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
University of Cambridge | College/University | Doctorate Degree Graduate Degree Graduate Degree Masters Business Admin Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Queen's University | College/University | Undergraduate Degree Doctorate Degree | |
GE Healthcare Ltd. (United Kingdom)
GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
University of London | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
The University of Texas at Austin | College/University | Undergraduate Degree Undergraduate Degree | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Masters Business Admin Graduate Degree | |
University of British Columbia | College/University | Doctorate Degree Masters Business Admin Doctorate Degree | |
University of Michigan | College/University | Graduate Degree Undergraduate Degree | |
Copenhagen Business School | College/University | Undergraduate Degree Graduate Degree | |
Ferring Holding SA
Ferring Holding SA Pharmaceuticals: MajorHealth Technology Ferring Holding SA operates as a holding company with interests in pharmaceutical products. The company was founded in 2000 and is headquartered in Saint-Prex, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ENDOCYTE, INC. | Pharmaceuticals: Major | Director/Board Member | |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Friedrich-Alexander University of Erlangen-Nuremberg | College/University | Doctorate Degree | |
University of Copenhagen | College/University | Graduate Degree Doctorate Degree | |
ESCP Europe Campus Paris | College/University | Graduate Degree Masters Business Admin | |
Icahn School of Medicine at Mount Sinai | College/University | Director/Board Member Director/Board Member | |
Interface Biologics, Inc.
Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | Information Technology Services | Corporate Officer/Principal | |
MRC Laboratory of Molecular Biology
MRC Laboratory of Molecular Biology Miscellaneous Commercial ServicesCommercial Services MRC Laboratory of Molecular Biology provides biological research and development services. it also offers methods for determining the three-dimensional structures of proteins and other macromolecules, the sequencing of DNA and the development of monoclonal antibodies. The company was founded by Max Ferdinand Perutz in 1962 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Operating Officer | |
Novo Seeds
Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor Director of Investments | |
i3 Innovus | Investment Managers | Corporate Officer/Principal | |
ADVANCED ACCELERATOR APPLICATION SA(ADR) | Medical Specialties | Chairman | |
Stevenage Bioscience Catalyst
Stevenage Bioscience Catalyst BiotechnologyHealth Technology Stevenage Bioscience Catalyst offers access to equipment and facilities that would otherwise be beyond the reach of small or medium-sized companies. The company is headquartered in Stevenage, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
RUBIUS THERAPEUTICS | Biotechnology | Director/Board Member Director/Board Member | |
Vetter Pharma International GmbH
Vetter Pharma International GmbH Medical DistributorsDistribution Services Part of Vetter Pharma-Fertigung Verwaltungs GmbH, Vetter Pharma International GmbH is a pharmaceutical service provider that offers comprehensive fill-and-finish services from clinical development to commercialization and beyond. The company is based in Ravensburg, Germany. The German company uses robust, well-controlled testing procedures to verify the quality of every product they release. Vetter is a family-owned company that provides expert manufacturing guidance for injectable drug products. The company has an exclusive collection of in-depth videos that customers can explore. Recently, they responded to increasing market demand by implementing additional equipment for aseptic production and expanding storage capacities at the clinical site. The company was founded in 2009, and the CEO is Peter Sölkner. | Medical Distributors | Director/Board Member | |
Novo Holdings A/S (Investment Company)
Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Chairman Chief Executive Officer | |
RENALYTIX PLC | Packaged Software | Corporate Secretary Director/Board Member | |
CIBA Vision GmbH (Germany)
CIBA Vision GmbH (Germany) Electronic ComponentsElectronic Technology Part of Alcon AG, CIBA Vision GmbH is a company based in Grosswallstadt, Germany. CIBA Vision GmbH manufactures and markets contact lenses. The German company was founded in 1983. The CEO is Norbert Dörr. | Electronic Components | Director/Board Member | |
VERICI DX PLC | Medical/Nursing Services | Corporate Secretary Director/Board Member | |
E. Merck KG
E. Merck KG Pharmaceuticals: MajorHealth Technology E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ripple Therapeutics Corp. | General Counsel | ||
Artbio, Inc.
Artbio, Inc. Hospital/Nursing ManagementHealth Services Artbio, Inc. is a company that is focused on redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building an ecosystem that maximizes their potential. Artbio is based in Cambridge, MA and has subsidiaries in Norway. The company puts the patient at the core of everything they do. The company was founded in 2021 by Emanuele Ostuni, Roy Hartvig Larsen, and Øyvind Sverre Bruland. Emanuele Ostuni has been the CEO since 2021. | Hospital/Nursing Management | Director/Board Member |
Estadísticas
Internacional
Estados Unidos | 19 |
Reino Unido | 12 |
Dinamarca | 8 |
Canadá | 6 |
Alemania | 5 |
Sectorial
Health Technology | 20 |
Consumer Services | 14 |
Miscellaneous | 5 |
Finance | 5 |
Commercial Services | 3 |
Operativa
Director/Board Member | 264 |
Corporate Officer/Principal | 96 |
Portfolio Manager-Equities | 49 |
Chairman | 46 |
Chief Executive Officer | 44 |
Las relaciones más conectadas
Insiders | |
---|---|
Frank Holler | 29 |
Abhijeet Lele | 27 |
Thomas Dyrberg | 24 |
Lars Rebien Sørensen | 22 |
Emmanuelle Coutanceau | 21 |
Kasim Kutay | 21 |
Søren Møller | 21 |
Viviane Monges | 21 |
Erik Lium | 17 |
Brett Whalen | 16 |
James Brown | 16 |
David Sable | 16 |
Ruth McKernan | 16 |
Steven J. Winick | 15 |
Daniel Abrams | 14 |
- Bolsa de valores
- Insiders
- Daniel Mahony
- Conexiones Empresas